The global sports medicine market was valued at USD 6.26 billion in 2018 and is expected to reach USD 13.86 billion by 2032, reflecting a compound annual growth rate of 5.8% over the forecast period. In 2018, North America accounted for the largest share of the market at 41.53%.
The global sports medicine market has witnessed steady growth in recent years and is projected to continue expanding over the coming decade. The market is driven by rising participation in sports, increasing incidence of related injuries, and ongoing technological advancements in treatment and rehabilitation. North America currently holds a leading position, supported by advanced healthcare infrastructure and strong adoption of innovative therapies, while other regions are showing significant potential for growth.
Learn more here:
https://www.fortunebusinessinsights.com/sports-medicine-market-102034
Market Segmentation
The market is segmented by product into body reconstruction solutions such as implants, fixation devices, arthroscopy instruments, and orthobiologics; body support and recovery products such as braces, supports, compression wear, and physiotherapy equipment; and body monitoring and evaluation tools including diagnostic and rehabilitation technologies along with tapes and consumables.
The market is segmented by application into treatment and prevention of knee, shoulder, ankle and foot, hip and groin, elbow and wrist, and spine injuries, with knee and shoulder care representing prominent use cases due to contact, pivoting, and overhead motions in many sports.
The market is segmented by end user into hospitals, ambulatory surgical centers, orthopedic and sports medicine clinics, rehabilitation centers, and fitness or training facilities, with hospitals handling complex procedures and clinics and centers focusing on outpatient care and rehab pathways.
The market is also segmented by injury type into acute traumatic injuries such as ligament tears and fractures and overuse conditions such as tendinopathies and stress injuries, with tailored protocols for each pathway from diagnosis to return to activity.
List Of Key Companies Profiled: